TARA Biosystems

company

About

TARA Biosystems Harnessing Human Biology + Data to Transform Cardiac Drug Discovery

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$9M
Industries
Biotechnology,Medical
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Tara Biosystems provides predictive, in vitro human cardiac tissue models for use in drug discovery, safety assessment and translational medicine. Tara Biosystems offers a high-fidelity solution that is based on human stem cell-derived cardiac tissue matured to physiologically relevant adult-like levels and provides direct measures of cardiac functionality, including contractile force. The company is dedicated to pioneering predictive cardiac tissue models that enable the faster, safer, and more reliable development of new medicines.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$19M
TARA Biosystems has raised a total of $19M in funding over 2 rounds. Their latest funding was raised on Jun 23, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 23, 2020 Series A $10M 1 Detail
Oct 16, 2017 Series A $9M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
TARA Biosystems is funded by 1 investors. Trancos Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Trancos Ventures Series A